ReviewBiomarker research2021
MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions.
Anja HarderPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papertrialcites it